BrainXell
BrainXell is a leading provider of hiPSC-derived neurons and glia, working with over 75% of the world’s largest pharmaceutical companies. Comprehensive off-the-shelf portfolio featuring key Alzheimer’s-related mutations (APOE, TREM2, APP, PSEN1, etc.) with matched isogenic controls. New dopaminergic neuron differentiation protocol generates high-purity cells capable of dopamine secretion by DIV 14. Robust, scalable manufacturing processes generate billions of cells, and flexible custom workflows deliver the same high-quality cell types from any customer-supplied iPSC line.
